Dexmedetomidine hydrochloride nasal spray

DRUG4 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd., Shanghai Hengrui Pharmaceutical Co., Ltd., Sichuan Provincial People's Hospital

Conditions

DexmedetomidineMonitored Anaesthesia CarePostoperative Delirium (POD)Preanesthetic MedicationPreoperative SedationPreoperative Sedation of ChildrenSafetySedation

Phase 1

A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children

CompletedNCT04200235

Jiangsu HengRui Medicine Co., Ltd.Preoperative Sedation

Start: 2020-01-06End: 2020-08-07Updated: 2020-09-09

Phase 3

A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children

CompletedNCT05111431

Shanghai Hengrui Pharmaceutical Co., Ltd.Preoperative Sedation of Children

Start: 2021-11-24End: 2022-05-20Updated: 2022-11-07

Phase 4

Safety Exploration and Evaluation of Dexmedetomidine Hydrochloride Nasal Spray for Pre-anesthesia Sedation in Low-Monitoring Settings

Not yet recruitingNCT07298525

Sichuan Provincial People's HospitalDexmedetomidine, Monitored Anaesthesia Care, Preanesthetic Medication +2

Start: 2026-01-10End: 2026-12-30Target: 564Updated: 2025-12-23

Dexmedetomidine Nasal Spray on Postoperative Delirium in Elderly Thoracoscopic Lung Resection Patients

Not yet recruitingNCT07579806

Sichuan Provincial People's HospitalPostoperative Delirium (POD)

Start: 2026-06-01End: 2026-12-31Target: 264Updated: 2026-05-12

Related Papers

Safety and efficacy of a novel dexmedetomidine nasal spray for pre-anesthetic sedation in children: a randomized, double-blind, placebo-controlled trial.

2024-09-067 citations